Bulgaria’s spending on generic medicines drastically below EU average [Partner Content]
Editorial abstract
Generic medicines account for 75% of pharmaceutical sales by volume in Bulgaria with less than 10% of public funding
This is not the publisher’s original article. Unreviewed abstracts are mechanically condensed from source-provided material; editor-reviewed abstracts have completed editorial review.Story classification
Topics
Economic Policy · Low confidence · AutomaticBroad source default; editorial correction recommended
Regions
Europe · High confidence · AutomaticStory-text location match